Bibliotecas PUC-SP - Busca Integrada

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

由 Arjun Balar, Dean F. Bajorin, Matthew I. Milowsky
发表在 Therapeutic Advances in Urology (2011-06-01)

Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer

由 Blaine Brower, Asia McCoy, Hiba Ahmad, Cheryl Eitman, I. Alex Bowman, Jennifer Rembisz, Matthew I. Milowsky, Matthew I. Milowsky
发表在 Frontiers in Oncology (2024-04-01)

Bladder preservation in muscle-invasive bladder cancer: a comprehensive review

由 Judy Hamad, Hannah McCloskey, Matthew I. Milowsky, Trevor Royce, Angela Smith
发表在 International Brazilian Journal of Urology (2020-02-01)

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion

由 Tämer El Saadany, Anja Lorch, Matthew I. Milowsky, Ursula Maria Vogl, Richard Cathomas
发表在 Frontiers in Oncology (2024-08-01)

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature

由 Dillon C. Cockrell, Raj S. Kasthuri, Ersan Altun, Tracy L. Rose, Matthew I. Milowsky
发表在 Case Reports in Oncology (2020-11-01)

Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)

由 Josip Vukina, David D. Chism, Julie L. Sharpless, Mathew C. Raynor, Matthew I. Milowsky, William K. Funkhouser
发表在 Case Reports in Pathology (2015-01-01)

A Case of Rapidly Progressive De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer

由 Aryan Dalal, Sean Clark-Garvey, Andrew Gdowski, Sophia Zhang, Sara E. Wobker, Steven P. Rowe, Ersan Altun, Himisha Beltran, Matthew I. Milowsky
发表在 Case Reports in Oncological Medicine (2024-01-01)

Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and R...

由 Catherine C. Fahey, Sean Clark-Garvey, Sima Porten, Ashish M. Kamat, Thomas W. Flaig, John A. Taylor, William Y. Kim, Matthew I. Milowsky
发表在 Current Oncology (2025-05-01)

Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications

由 Kristin Weiss, Kathryn H. Gessner, Alysen Demzik, Elizabeth Moreton, William Y. Kim, Sara E. Wobker, Tracy L. Rose, Matthew I. Milowsky, Marc A. Bjurlin
发表在 Cancer Treatment and Research Communications (2023-01-01)

Inflammatory myofibroblastic tumor in a patient with X-Linked hypophosphatemia: A case of Occam's razor or Hickam's dictum?

由 Farhan Chowdry, Kelsey M. Miller, Ersan Altun, Sara E. Wobker, Gary S. Gottesman, Hikmat Al-Ahmadie, Tracy L. Rose, Eric M. Wallen, Matthew I. Milowsky
发表在 Urology Case Reports (2024-05-01)

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

由 Stephanie I Kim, Andy H Szeto, Katherine P Morgan, Blaine Brower, Mary W Dunn, Amir H Khandani, Paul A Godley, Tracy L Rose, Ethan M Basch, Matthew I Milowsky, Young E Whang, Daniel J Crona
发表在 PLoS ONE (2021-01-01)

Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

由 Stephanie I. Kim, Andy H. Szeto, Katherine P. Morgan, Blaine Brower, Mary W. Dunn, Amir H. Khandani, Paul A. Godley, Tracy L. Rose, Ethan M. Basch, Matthew I. Milowsky, Young E Whang, Daniel J Crona
发表在 PLoS ONE (2021-01-01)

Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer

由 Jeffrey S. Damrauer, Wolfgang Beckabir, Jeff Klomp, Mi Zhou, Elizabeth R. Plimack, Matthew D. Galsky, Petros Grivas, Noah M. Hahn, Peter H. O’Donnell, Gopa Iyer, David I. Quinn, Benjamin G. Vincent, Diane Zipursky Quale, Sara E. Wobker, Katherine A. Hoadley, William Y. Kim, Matthew I. Milowsky
发表在 Nature Communications (2022-11-01)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

由 Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, Jonathan E. Rosenberg
发表在 Journal for ImmunoTherapy of Cancer (2017-08-01)

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

由 Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, Jonathan E. Rosenberg
发表在 Journal for ImmunoTherapy of Cancer (2017-09-01)

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer

由 Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P. Vensko, Mark G. Woodcock, Hsing-Hui Wang, Sara E. Wobker, Gatphan Atassi, Alec D. Wilkinson, Kenneth Fowler, Leah M. Flick, Jeffrey S. Damrauer, Michael R. Harrison, Karen P. McKinnon, Tracy L. Rose, Matthew I. Milowsky, Jonathan S. Serody, William Y. Kim, Benjamin G. Vincent
发表在 Nature Communications (2024-05-01)

Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule

由 Małgorzata A. Witek, Rachel D. Aufforth, Hong Wang, Joyce W. Kamande, Joshua M. Jackson, Swathi R. Pullagurla, Mateusz L. Hupert, Jerry Usary, Weiya Z. Wysham, Dawud Hilliard, Stephanie Montgomery, Victoria Bae-Jump, Lisa A. Carey, Paola A. Gehrig, Matthew I. Milowsky, Charles M. Perou, John T. Soper, Young E. Whang, Jen Jen Yeh, George Martin, Steven A. Soper
发表在 npj Precision Oncology (2017-07-01)

FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression

由 Atsushi Okato, Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Luiza D. Pereira, Ting Chen, Yuki Kita, Di Wu, Hyesun Hyun, Hyojin Lee, Andrew S. Gdowski, John D. Raupp, Sean Clark-Garvey, Ujjawal Manocha, Alison Chafitz, Fiona Sherman, Janaye Stephens, Tracy L. Rose, Matthew I. Milowsky, Sara E. Wobker, Jonathan S. Serody, Jeffrey S. Damrauer, Kwok-Kin Wong, William Y. Kim
发表在 The Journal of Clinical Investigation (2024-01-01)

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

由 Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath, Scott T. Tagawa, Dana E. Rathkopf, Matthew I. Milowsky, Michael R. Harrison, Tomasz M. Beer, Arjun V. Balar, Andrew J. Armstrong, Daniel J. George, Channing J. Paller, Arlyn Apollo, Daniel C. Danila, Julie N. Graff, Luke Nordquist, Erica S. Dayan Cohn, Kin Tse, Nicole A. Schreiber, Glenn Heller, Howard I. Scher
发表在 European Urology Open Science (2021-12-01)

Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

由 Amanda Nizam, Charles B. Nguyen, Jinju Li, Emily C. Zabor, Pavlos Msaouel, Cindy Y. Jiang, Omar Alhalabi, Eugene Oh, Matthew P. Davidsohn, Ilana B. Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder, Tanya Jindal, Amy K. Taylor, Michael J. Glover, Ali Raza Khaki, Emily Lemke, Hannah Mabey, Bashar Abuqayas, Albert Jang, Jason R. Brown, Sean T. Evans, Cameron Pywell, Arnab Basu, Mehmet A. Bilen, Pedro C. Barata, Yousef Zakharia, Matthew I. Milowsky, Deepak Kilari, Christopher J. Hoimes, Sumit A. Shah, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Petros Grivas, Joaquim Bellmunt, Matthew T. Campbell, Ajjai S. Alva, Vadim S. Koshkin
发表在 Cancer Medicine (2025-10-01)